{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Berberis vulgaris", "berberine", "bioavailability", "distribution", "excretion", "metabolism", "pharmacokinetics"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36221815", "DateCompleted": {"Year": "2022", "Month": "11", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "11", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.7589"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "36", "Issue": "11", "PubDate": {"Year": "2022", "Month": "Nov"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive review.", "Pagination": {"StartPage": "4063", "EndPage": "4079", "MedlinePgn": "4063-4079"}, "Abstract": {"AbstractText": ["Barberry (Berberis vulgaris L.) is a medicinal plant and its main constituent is an isoquinoline alkaloid named berberine that has multiple pharmacological effects such as antioxidant, anti-microbial, antiinflammatory, anticancer, anti-diabetes, anti-dyslipidemia, and anti-obesity. However, it has restricted clinical uses due to its very poor solubility and bioavailability (less than 1%). It undergoes demethylenation, reduction, and cleavage of the dioxymethylene group in the first phase of metabolism. Its phase two reactions include glucuronidation, sulfation, and methylation. The liver is the main site for berberine distribution. Berberine could excrete in feces, urine, and bile. Fecal excretion of berberine (11-23%) is higher than urinary and biliary excretion routes. However, a major berberine metabolite is excreted in urine greater than in feces. Concomitant administration of berberine with other drugs such as metformin, cyclosporine A, digoxin, etc. may result in important interactions. Thus, in this review, we gathered and dissected any related animal and human research articles regarding the pharmacokinetic parameters of berberine including bioavailability, metabolism, distribution, excretion, and drug-drug interactions. Also, we discussed and gathered various animal and human studies regarding the developed products of berberine with better bioavailability and consequently, better therapeutic effects."], "CopyrightInformation": "\u00a9 2022 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0002-7316-5426"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Khoshandam", "ForeName": "Arian", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Imenshahidi", "ForeName": "Mohsen", "Initials": "M"}, {"Identifier": ["0000-0002-3483-851X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Hosseinzadeh", "ForeName": "Hossein", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Berberis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alolga, R. N., Fan, Y., Chen, Z., Liu, L., Zhao, Y., Li, J., & Chen, Y. (2016). Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. Nature Publishing Group, 6(1), 27671. https://doi.org/10.1038/srep27671"}, {"Citation": "Azadi, R., Mousavi, S. E., Kazemi, N. M., Yousefi-Manesh, H., Rezayat, S. M., & Jaafari, M. R. (2021). Anti-inflammatory efficacy of Berberine Nanomicelle for improvement of cerebral ischemia: Formulation, characterization and evaluation in bilateral common carotid artery occlusion rat model. BMC Pharmacology and Toxicology, 22(1), 1-10. https://doi.org/10.1186/s40360-021-00525-7"}, {"Citation": "Bhattacharjee, K., Nath, M., & Choudhury, Y. (2021). Berberine is as effective as the anti-obesity drug Orlistat in ameliorating betel-nut induced dyslipidemia and oxidative stress in mice. Phytomedicine Plus, 1(3), 100098. https://doi.org/10.1016/j.phyplu.2021.100098"}, {"Citation": "Boto, R. E. F., Almeida, P., & Queiroz, J. A. (2008). Thiacarbocyanine as ligand in dye-affinity chromatography. Biomedical Chromatography, 288(3), 278-288. https://doi.org/10.1002/bmc"}, {"Citation": "Chang, Z. M., Li, X. D., Wang, Z., Wang, X. R., Shao, D., Zhang, X., \u2026 Dong, W. F. (2019). Berberine-loaded janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition. International Journal of Nanomedicine, 29(14), 3967-3982. https://doi.org/10.2147/IJN.S206044"}, {"Citation": "Chen, H.-Y., Ye, X.-L., Cui, X.-L., He, K., Jin, Y.-N., Chen, Z., & Li, X.-G. (2012). Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells. Fitoterapia, 83(1), 67-73. https://doi.org/10.1016/j.fitote.2011.09.014"}, {"Citation": "Chen, H. X., Huang, J. L., & Li, J. (2010). Structural elucidation of in vivo and in vitro metabolites of epiberberine in rat and its liver and intestines by liquid chromatography-tandem mass spectrometry. Analytical Letters, 43(16), 2505-2517. https://doi.org/10.1080/00032711003725607"}, {"Citation": "Chen, J.-L., Zhang, Y.-L., Dong, Y., Zhang, L., Liu, D., Yang, J.-L., \u2026 Cui, H.-M. (2013). Enzyme reaction kinetics, metabolic enzyme phenotype, and metabolites of berberine. Chinese Traditional and Herbal Drugs, 44(23), 3334-3340. https://doi.org/10.7501/j.issn.0253-2670.2013.23.014"}, {"Citation": "Chen, N., Guo, C. E., Chen, H., Chen, J., Bi, X., Li, H., \u2026 Lin, H. (2018). Simultaneous determination of six coptis alkaloids in urine and feces by LC-MS/MS and its application to excretion kinetics and the compatibility mechanism of Jiao-tai-wan in insomniac rats. Biomedical Chromatography, 32(8), e4248. https://doi.org/10.1002/bmc.4248"}, {"Citation": "Chen, W., Miao, Y. Q., Fan, D. J., Yang, S. S., Lin, X., Meng, L. K., & Tang, X. (2011). Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech, 12(2), 705-711. https://doi.org/10.1208/s12249-011-9632-z"}, {"Citation": "Chen, Z., Zheng, S., Li, L., & Jiang, H. (2014). Metabolism of flavonoids in human: A comprehensive review. Current Drug Metabolism, 15(1), 48-61. https://doi.org/10.2174/138920021501140218125020"}, {"Citation": "Choudhury, D., Jala, A., Murty, U. S., Borkar, R. M., & Banerjee, S. (2022). In vitro and in vivo evaluations of berberine-loaded microparticles filled in-house 3D printed hollow capsular device for improved oral bioavailability. AAPS PharmSciTech, 23(4), 1-16. https://doi.org/10.1208/s12249-022-02241-9"}, {"Citation": "Cicero, A. F. G., Fogacci, F., Bove, M., Giovannini, M., Veronesi, M., & Borghi, C. (2019). Short-term effects of dry extracts of artichokeand berberis in hypercholesterolemic patients without cardiovascular disease. American Journal of Cardiology, 123(4), 588-591. https://doi.org/10.1016/j.amjcard.2018.11.018"}, {"Citation": "Colombo, D., Lunardon, L., & Bellia, G. (2014). Cyclosporine and herbal supplement interactions. Journal of Toxicology, 2014(2014), 145325. https://doi.org/10.1155/2014/145325"}, {"Citation": "Cui, H. X., Hu, Y. N., Li, J. W., Yuan, K., & Guo, Y. (2019). Preparation and evaluation of antidiabetic agents of berberine organic acid salts for enhancing the bioavailability. Molecules, 24(1), 103. https://doi.org/10.3390/molecules24010103"}, {"Citation": "Dai, G., Sun, B., Wu, L., Gao, X., Song, S., Sun, H., & Ju, W. (2018). Comparative pharmacokinetics of three alkaloids in normal and acute hepatitis rats after oral administration of Yanhuanglian total alkaloids extract. Biomedical Chromatography, 32(11), e4329. https://doi.org/10.1002/bmc.4329"}, {"Citation": "Deng, J., Zhao, L., Yuan, X., Li, Y., Shi, J., Zhang, H., \u2026 Zou, F. (2022). Pre-administration of berberine exerts chemopreventive effects in AOM/DSS-induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota. Nutrients, 14(4), 726. https://doi.org/10.3390/nu14040726"}, {"Citation": "Di Pierro, F., Putignano, P., Villanova, N., Montesi, L., Moscatiello, S., & Marchesini, G. (2013). Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clinical Pharmacology: Advances and Applications, 19(5), 167-174. https://doi.org/10.2147/CPAA.S54308"}, {"Citation": "Duong, T. T., Yen, T. T. H., Nguyen, L. T., Nguyen, T. D., Nguyen, T. Q. T., Nghiem, T. H. L., \u2026 Pham, T. M. H. (2022). Berberine-loaded liposomes for oral delivery: Preparation, physicochemical characterization and in-vivo evaluation in an endogenous hyperlipidemic animal model. International Journal of Pharmaceutics, 616, 121525. https://doi.org/10.1016/j.ijpharm.2022.121525"}, {"Citation": "Feng, R., Shou, J. W., Zhao, Z. X., He, C. Y., Ma, C., Huang, M., \u2026 Jiang, J. D. (2015). Transforming berberine into its intestine-absorbable form by the gut microbiota. Scientific Reports, 5(1), 1-15. https://doi.org/10.1038/srep12155"}, {"Citation": "Feng, X., Wang, K., Cao, S., Ding, L., & Qiu, F. (2021). Pharmacokinetics and excretion of berberine and its nine metabolites in rats. Frontiers in Pharmacology, 15(11), 594852. https://doi.org/10.3389/fphar.2020.594852"}, {"Citation": "Fratter, A., & De Servi, B. (2015). New oral delivery system to improve absorption of berberine: Likely interaction of cationized chitosan with PG-P pump. International Journal of Drug Delivery Technology, 5(1), 33-42. https://doi.org/10.25258/IJDDT.V5I1.8866"}, {"Citation": "Gendy, A. M., Elnagar, M. R., Allam, M. M., Mousa, M. R., Khodir, A. E., El-Haddad, A. E., \u2026 El-Mancy, S. S. (2022). Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-\u03baB signaling and autophagy. Biomedicine and Pharmacotherapy, 145, 112122. https://doi.org/10.1016/j.biopha.2021.112122"}, {"Citation": "Ghaffarzadegan, R., Khoee, S., & Rezazadeh, S. (2020). Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release. DARU, Journal of Pharmaceutical Sciences, 28(1), 237-252. https://doi.org/10.1007/s40199-020-00335-y"}, {"Citation": "Godugu, C., Patel, A. R., Doddapaneni, R., Somagoni, J., & Singh, M. (2014). Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. PLoS One, 9(3), e89919. https://doi.org/10.1371/journal.pone.0089919"}, {"Citation": "Grebinyk, A., Prylutska, S., Grebinyk, S., Evstigneev, M., Krysiuk, I., Skaterna, T., \u2026 Frohme, M. (2021). Antitumor efficiency of the natural alkaloid berberine complexed with C60 fullerene in Lewis lung carcinoma in vitro and in vivo. Cancer Nanotechnology, 12(1), 1-18. https://doi.org/10.1186/s12645-021-00096-6"}, {"Citation": "Gui, S. Y., Wu, L., Peng, D. Y., Liu, Q. Y., Yin, B. P., & Shen, J. Z. (2008). Preparation and evaluation of a microemulsion for oral delivery of berberine. Die Pharmazie, 63(7), 516-519. https://doi.org/10.1691/ph.2008.8018"}, {"Citation": "Guo, Y., Li, F., Ma, X., Cheng, X., Zhou, H., & Klaassen, C. D. (2011). CYP2D plays a major role in berberine metabolism in liver of mice and humans. Xenobiotica, 41(11), 996-1005. https://doi.org/10.3109/00498254.2011.597456"}, {"Citation": "Gupta, S., Gupta, R., & Gupta, J. (2021). Evaluation of pharmacodynamic interaction between berberine and antibacterial drug (azithromycin) in albino Wistar rats. Current Trends in Biotechnology and Pharmacy, 15(3), 256-267. https://doi.org/10.5530/ctbp.2021.3.28"}, {"Citation": "Habtemariam, S. (2020). Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacological Research, 155(5), 104722. https://doi.org/10.1016/j.phrs.2020.104722"}, {"Citation": "Han, F., Zhu, M., Chen, H., & Chen, Y. (2006). Liquid chromatography-tandem electrospray ionization ion trap mass spectrometric assay for the metabolites of jatrorrhizine in rat urine. Yao xue xue bao=Acta Pharmaceutica Sinica, 41(9), 846-851."}, {"Citation": "Hua, W., Ding, L., Chen, Y., Gong, B., He, J., & Xu, G. (2007). Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 44(4), 931-937. https://doi.org/10.1016/j.jpba.2007.03.022"}, {"Citation": "Imenshahidi, M., & Hosseinzadeh, H. (2016). Berberis vulgaris and berberine: An update review. Phytotherapy Research, 30(11), 1745-1764. https://doi.org/10.1002/ptr.5693"}, {"Citation": "Imenshahidi, M., & Hosseinzadeh, H. (2019). Berberine and barberry (Berberis vulgaris): A clinical review. Phytotherapy Research, 33(3), 504-523. https://doi.org/10.1002/ptr.6252"}, {"Citation": "Jang, M. H., Piao, X. L., Kim, J. M., Kwon, S. W., & Park, J. H. (2008). Inhibition of cholinesterase and amyloid-&bgr; aggregation by resveratrol oligomers from Vitis amurensis. Phytotherapy Research, 22(4), 544-549. https://doi.org/10.1002/ptr.2406"}, {"Citation": "Jia, J., Zhang, K., Zhou, X., Ma, J., Liu, X., Xiang, A., & Ge, F. (2019). Berberine-loaded solid proliposomes prepared using solution enhanced dispersion by supercritical CO 2: Sustained release and bioavailability enhancement. Journal of Drug Delivery Science and Technology, 51, 356-363. https://doi.org/10.1016/j.jddst.2019.03.021"}, {"Citation": "Jin, H., Li, J., Zhang, M., Luo, R., Lu, P., Zhang, W., \u2026 Huang, G. (2021). Berberine-loaded biomimetic nanoparticles attenuate inflammation of experimental allergic asthma via enhancing IL-12 expression. Frontiers in Pharmacology, 12, 724525. https://doi.org/10.3389/fphar.2021.724525"}, {"Citation": "Ju, Y., Qiu, W., Jiang, X., & Liu, C. (2011). Effect of berberine on pharmacokinetics of digoxin after oral administration to rats. Zhongguo Zhongyao Zazhi, 36(7), 918-921. https://doi.org/10.4268/cjcmm20110721"}, {"Citation": "Pan, J.-F., Chen, Y., Zhu, D.-Y., Zhang, H., Zeng, J.-F., & Shan-Hao Jiang, J.-Y. R. (2002). Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration. Acta Pharmaceutica Sinica B, 23(1), 77-82."}, {"Citation": "Khvostov, M. V., Gladkova, E. D., Borisov, S. A., Zhukova, N. A., Marenina, M. K., Meshkova, Y. V., \u2026 Salakhutdinov, N. F. (2021). Discovery of the first in class 9-N-berberine derivative as hypoglycemic agent with extra-strong action. Pharmaceutics, 13(12), 2138. https://doi.org/10.3390/pharmaceutics13122138"}, {"Citation": "Kohli, K., Mujtaba, A., Malik, R., Amin, S., Alam, M. S., Ali, A., \u2026 Ansari, M. J. (2021). Development of natural polysaccharide-based nanoparticles of berberine to enhance oral bioavailability: Formulation, optimization, ex vivo, and in vivo assessment. Polymers, 13(21), 3833. https://doi.org/10.3390/polym13213833"}, {"Citation": "Kutbi, H. I., Asfour, H. Z., Kammoun, A. K., Sirwi, A., Cavalu, S., & Gad, H. A. (2021). Optimization of hyaluronate-based liposomes to augment the oral delivery and the bioavailability of berberine. Materials, 14(19), 5759. https://doi.org/10.3390/ma14195759"}, {"Citation": "Kwon, M., Choi, Y. A., Choi, M.-K., & Song, I.-S. (2015). Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin. Archives of Pharmacal Research, 38(5), 849-856. https://doi.org/10.1007/s12272-014-0510-6"}, {"Citation": "Kwon, M., Lim, D. Y., Lee, C. H., Jeon, J. H., Choi, M. K., & Song, I. S. (2020). Enhanced intestinal absorption and pharmacokinetic modulation of berberine and its metabolites through the inhibition of p-glycoprotein and intestinal metabolism in rats using a berberine mixed micelle formulation. Pharmaceutics, 12(9), 882. https://doi.org/10.3390/pharmaceutics12090882"}, {"Citation": "Li, G., Yang, F., Liu, M., Su, X., Zhao, M., & Zhao, L. (2016). Development and application of a UPLC-MS/MS method for simultaneous determination of fenofibric acid and berberine in rat plasma: Application to the drug-drug pharmacokinetic interaction study of fenofibrate combined with berberine after oral administrati. Biomedical Chromatography, 30(7), 1075-1082. https://doi.org/10.1002/bmc.3652"}, {"Citation": "Li, J., Du, H., Zhang, M., Zhang, Z., Teng, F., Zhao, Y., \u2026 Chen, L. (2019). Amorphous solid dispersion of berberine mitigates apoptosis via iPLA2\u03b2/cardiolipin/opa1 pathway in db/db mice and in palmitate-treated MIN6 \u03b2-cells. International Journal of Biological Sciences, 15(7), 1533-1545. https://doi.org/10.7150/ijbs.32020"}, {"Citation": "Li, Y., Ren, G., Wang, Y. X., Kong, W. J., Yang, P., Wang, Y. M., \u2026 Jiang, J. D. (2011). Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. Journal of Translational Medicine, 15(9), 62. https://doi.org/10.1186/1479-5876-9-62"}, {"Citation": "Liu, C. S., Zheng, Y. R., Zhang, Y. F., & Long, X. Y. (2016). Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia, 109, 274-282. https://doi.org/10.1016/j.fitote.2016.02.001"}, {"Citation": "Liu, Y., Hao, H., Xie, H., Lv, H., Liu, C., & Wang, G. (2009). Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats. Journal of Pharmaceutical Sciences, 98(11), 4391-4401. https://doi.org/10.1002/jps.21721"}, {"Citation": "Liu, Y. T., Hao, H. P., Xie, H. G., Lai, L., Wang, Q., Liu, C. X., & Wang, G. J. (2010). Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metabolism and Disposition, 38(10), 1779-1784. https://doi.org/10.1124/dmd.110.033936"}, {"Citation": "Lohan, S., Sharma, T., Saini, S., Singh, A., Kumar, A., Raza, K., \u2026 Singh, B. (2021). Galactosylated nanoconstructs of berberine with enhanced biopharmaceutical and cognitive potential: A preclinical evidence in Alzheimer's disease. Journal of Drug Delivery Science and Technology, 66, 102695. https://doi.org/10.1016/j.jddst.2021.102695"}, {"Citation": "Loo, Y. S., Madheswaran, T., Rajendran, R., & Bose, R. J. (2020). Encapsulation of berberine into liquid crystalline nanoparticles to enhance its solubility and anticancer activity in MCF7 human breast cancer cells. Journal of Drug Delivery Science and Technology, 57, 101756. https://doi.org/10.1016/j.jddst.2020.101756"}, {"Citation": "Lv, X. Y., Li, J., Zhang, M., Wang, C. M., Fan, Z., Wang, C. Y., & Chen, L. (2010). Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine. AAPS PharmSciTech, 11(1), 372-382. https://doi.org/10.1208/s12249-010-9386-z"}, {"Citation": "Ma, J. Y., Feng, R., Tan, X. S., Ma, C., Shou, J. W., Fu, J., \u2026 Jiang, J. D. (2013). Excretion of berberine and its metabolites in oral administration in rats. Journal of Pharmaceutical Sciences, 102(11), 4181-4192. https://doi.org/10.1002/jps.23718"}, {"Citation": "Maher, S., Leonard, T. W., Jacobsen, J., & Brayden, D. J. (2009). Safety and efficacy of sodium caprate in promoting oral drug absorption: From in vitro to the clinic. Advanced Drug Delivery Reviews, 61(15), 1427-1449. https://doi.org/10.1016/j.addr.2009.09.006"}, {"Citation": "Maiti, P., Plemmons, A., & Dunbar, G. L. (2019). Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments. PLoS One, 14(12), e0225660. https://doi.org/10.1371/journal.pone.0225660"}, {"Citation": "Mao, X., Zhao, H., Wang, Q., Li, H., Yang, L., Hu, Z., \u2026 Zheng, J. (2019). Metabolism-based herb-drug interaction of corydalis bungeanae herba with berberine in vitro and in vivo in rats. Biomedical Chromatography, 33(7), e4514. https://doi.org/10.1002/bmc.4514"}, {"Citation": "Marino, M., Gardana, C., Scialpi, A., Giorgini, G., Simonetti, P., & Del Bo, C. (2021). An in vitro approach to study the absorption of a new oral formulation of berberine. PharmaNutrition, 18, 100279. https://doi.org/10.1016/j.phanu.2021.100279"}, {"Citation": "McCubrey, J. A., Abrams, S. L., Steelman, L. S., Cocco, L., Ratti, S., Martelli, A. M., \u2026 Duda, P. (2022). APR-246-The mutant TP53 reactivator-Increases the effectiveness of berberine and modified berberines to inhibit the proliferation of pancreatic cancer cells. Biomolecules, 12(2), 276. https://doi.org/10.3390/biom12020276"}, {"Citation": "Mohammadzadeh, N., Mehri, S., & Hosseinzadeh, H. (2017). Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities. Iranian Journal of Basic Medical Sciences, 20(5), 538-551. https://doi.org/10.22038/ijbms.2017.8678"}, {"Citation": "Moon, J. M., Ratliff, K. M., Hagele, A. M., Stecker, R. A., Mumford, P. W., & Kerksick, C. M. (2022). Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: A randomized, controlled, crossover pilot trial. Nutrients, 14(1), 124. https://doi.org/10.3390/nu14010124"}, {"Citation": "Nguyen, M. T. H., Nguyen, L. L., Kim, T. H., Jung, W. K., & Nguyen, P. T. M. (2021). Berberine loaded nanoparticles induce apoptosis in human fibrosarcoma cells. Chiang Mai Journal of Science, 48(1), 123-134."}, {"Citation": "Paudel, K. R., Mehta, M., Yin, G. H. S., Yen, L. L., Malyla, V., Patel, V. K., \u2026 Dua, K. (2022). Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Environmental Science and Pollution Research, 2022(2022), 46830-46847. https://doi.org/10.1007/s11356-022-19158-2"}, {"Citation": "Petrangolini, G., Corti, F., Ronchi, M., Arnoldi, L., Allegrini, P., & Riva, A. (2021). Development of an innovative berberine food-grade formulation with an ameliorated absorption: In vitro evidence confirmed by healthy human volunteers pharmacokinetic study. Evidence-Based Complementary and Alternative Medicine, 2021(2021), 7563889. https://doi.org/10.1155/2021/7563889"}, {"Citation": "Porru, E., Franco, P., Calabria, D., Spinozzi, S., Roberti, M., Caliceti, C., & Roda, A. (2018). Combined analytical approaches to define biodistribution and biological activity of semi-synthetic berberrubine, the active metabolite of natural berberine. Analytical and Bioanalytical Chemistry, 410(15), 3533-3545. https://doi.org/10.1007/s00216-018-0884-2"}, {"Citation": "Qiu, W., Jiang, X. H., Liu, C. X., Ju, Y., & Jin, J. X. (2009). Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytotherapy Research, 23(11), 1553-1558. https://doi.org/10.1002/ptr.2808"}, {"Citation": "Qiu, F., Zhu, Z., Kang, N., Piao, S., Qin, G., & Yao, X. (2008). Isolation and identification of urinary metabolites of berberine. Drug Metabolism and Disposition, 36(11), 2159-2165. https://doi.org/10.1124/dmd.108.021659"}, {"Citation": "Sadeghnia, H. R., Kolangikhah, M., Asadpour, E., Forouzanfar, F., & Hosseinzadeh, H. (2017). Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells. Iranian Journal of Basic Medical Sciences, 20(5), 594-603. https://doi.org/10.22038/IJBMS.2017.8847"}, {"Citation": "Sadeghnia, H. R., Taji, A. R., Forouzanfar, F., & Hosseinzadeh, H. (2017). Berberine attenuates convulsing behavior and extracellular glutamate and aspartate changes in 4-aminopyridine treated rats. Iranian Journal of Basic Medical Sciences, 20(5), 588-593. https://doi.org/10.22038/IJBMS.2017.8756"}, {"Citation": "Sahibzada, M. U. K., Sadiq, A., Sfaidah, H., Khurram, M., Amin, M. U., Haseeb, A., & Kakar, M. (2018). Berberine nanoparticles with enhanced in vitro bioavailability: Characterization and antimicrobial activity. Drug Design, Development and Therapy, 12, 303-312. https://doi.org/10.2147/DDDT.S156123"}, {"Citation": "Sahibzada, M. U. K., Zahoor, M., Sadiq, A., Ur Rehman, F., Al-Mohaimeed, A. M., Shahid, M., \u2026 Ullah, R. (2021). Bioavailability and hepatoprotection enhancement of berberine and its nanoparticles prepared by liquid antisolvent method. Saudi Journal of Biological Sciences, 28(1), 327-332. https://doi.org/10.1016/j.sjbs.2020.10.006"}, {"Citation": "Sailor, G. U., Ramani, V. D., Shah, N., Parmar, G. R., Gohil, D., Balaraman, R., & Seth, A. A. (2021). Design of experiment approach based formulation optimization of berberine loaded solid lipid nanoparticle for antihyperlipidemic activity. Indian Journal of Pharmaceutical Sciences, 83(2), 204-218. https://doi.org/10.36468/pharmaceutical-sciences.766"}, {"Citation": "Saleh, S. R., Abady, M. M., Nofal, M., Yassa, N. W., Abdel-Latif, M. S., Nounou, M. I., \u2026 Abdel-Monaem, N. (2021). Berberine nanoencapsulation attenuates hallmarks of scoplomine induced alzheimer's-like disease in rats. Current Reviews in Clinical and Experimental Pharmacology, 16(2), 139-154. https://doi.org/10.2174/1574884715666200628112844"}, {"Citation": "Shi, R., Zhou, H., Ma, B., Ma, Y., Wu, D., Wang, X., \u2026 Cheng, N. (2012). Pharmacokinetics and metabolism of jatrorrhizine, a gastric prokinetic drug candidate. Biopharmaceutics and Drug Disposition, 33(3), 135-145. https://doi.org/10.1002/bdd.1779"}, {"Citation": "Shi, R., Yang, Y., Xu, Z., Dai, Y., Zheng, M., Wang, T., \u2026 Ma, Y. (2018). Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats. Biopharmaceutics and Drug Disposition, 39(1), 47-58. https://doi.org/10.1002/bdd.2112"}, {"Citation": "Shou, J.-W., Li, X.-X., Tang, Y.-S., Lim-Ho Kong, B., Wu, H.-Y., Xiao, M.-J., \u2026 Shaw, P.-C. (2022). Novel mechanistic insight on the neuroprotective effect of berberine: The role of PPAR\u03b4 for antioxidant action. Free Radical Biology and Medicine, 181, 62-71. https://doi.org/10.1016/j.freeradbiomed.2022.01.022"}, {"Citation": "Singh, A., Zhao, K., Bell, C., & Shah, A. J. (2020). Effect of berberine on in vitro metabolism of sulfonylureas: A herb-drug interactions study. Rapid Communications in Mass Spectrometry, 34(S4), e8651. https://doi.org/10.1002/rcm.8651"}, {"Citation": "Solanki, R., Patel, K., & Patel, S. (2021). Bovine serum albumin nanoparticles for the efficient delivery of berberine: Preparation, characterization and in vitro biological studies. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 608, 125501. https://doi.org/10.1016/j.colsurfa.2020.125501"}, {"Citation": "Spinozzi, S., Colliva, C., Camborata, C., Roberti, M., Ianni, C., Neri, F., \u2026 Roda, A. (2014). Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects. Journal of Natural Products, 77(4), 766-772. https://doi.org/10.1021/np400607k"}, {"Citation": "Tabeshpour, J., Imenshahidi, M., & Hosseinzadeh, H. (2017). A review of the effects of berberis vulgaris and its major component, berberine, in metabolic syndrome. Iranian Journal of Basic Medical Sciences, 20(5), 557-568. https://doi.org/10.22038/ijbms.2017.8682"}, {"Citation": "Tan, X. S., Ma, J. Y., Feng, R., Ma, C., Chen, W. J., Sun, Y. P., \u2026 Jiang, J. D. (2013). Tissue distribution of berberine and its metabolites after oral administration in rats. PLoS One, 8(10), e77969. https://doi.org/10.1371/journal.pone.0077969"}, {"Citation": "Tian, Y., Tang, G., Gao, Y., Chen, X., Zhou, Z., Li, Y., \u2026 Cao, Y. (2022). Carrier-free small molecular self-assembly based on berberine and curcumin incorporated in submicron particles for improving antimicrobial activity. ACS Applied Materials and Interfaces, 14(8), 10055-10067. https://doi.org/10.1021/acsami.1c22900"}, {"Citation": "Tsai, P.-L., & Tsai, T.-H. (2004). Hepatobiliary excretion of berberine. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 32(4), 405-412. https://doi.org/10.1124/dmd.32.4.405"}, {"Citation": "Wang, A., Yang, W., Yang, X., Mei, X., Hu, T., Liang, R., \u2026 Yan, D. (2020). MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability. Biomedicine and Pharmacotherapy, 127, 110140. https://doi.org/10.1016/j.biopha.2020.110140"}, {"Citation": "Wang, K., & Qiu, F. (2013). Curcuminoid metabolism and its contribution to the pharmacological effects. Current Drug Metabolism, 14(7), 791-806. https://doi.org/10.2174/13892002113149990102"}, {"Citation": "Wang, L., Kong, H., Jin, M., Li, X., Stoika, R., Lin, H., & Liu, K. (2020). Synthesis of disaccharide modified berberine derivatives and their anti-diabetic investigation in zebrafish using a fluorescence-based technology. Organic and Biomolecular Chemistry, 18(18), 3563-3574. https://doi.org/10.1039/d0ob00327a"}, {"Citation": "Wang, Q. S., Li, K., Gao, L. N., Zhang, Y., Lin, K. M., & Cui, Y. L. (2020). Intranasal delivery of berberine: Via in situ thermoresponsive hydrogels with non-invasive therapy exhibits better antidepressant-like effects. Biomaterials Science, 8(10), 2853-2865. https://doi.org/10.1039/c9bm02006c"}, {"Citation": "Wang, T., Wang, N., Song, H., Xi, X., Wang, J., Hao, A., & Li, T. (2011). Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine. European Journal of Pharmaceutical Sciences, 44(1-2), 127-135. https://doi.org/10.1016/j.ejps.2011.06.015"}, {"Citation": "Wang, Y., Tong, Q., Shou, J., Zhao, Z., Li, X., & Zhang, X. (2017). Gut microbiota-mediated personalized treatment of hyperlipidemia using Berberine. Theranostics, 7(9), 2443-2451. https://doi.org/10.7150/thno.18290"}, {"Citation": "Wang, Z. Z., Li, K., Maskey, A. R., Huang, W., Toutov, A. A., Yang, N., \u2026 Li, X. M. (2021). A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study. FASEB Journal, 35(4), e21360. https://doi.org/10.1096/fj.202001792R"}, {"Citation": "Wu, X., Li, Q., Xin, H., Yu, A., & Zhong, M. (2005). Effects of berberine on the blood concentration of cyclosporin a in renal transplanted recipients: Clinical and pharmacokinetic study. European Journal of Clinical Pharmacology, 61(8), 567-572. https://doi.org/10.1007/s00228-005-0952-3"}, {"Citation": "Xia, Y., Wang, G., Yu, E., Tian, J., Li, Z., Zhang, K., \u2026 Xie, J. (2022). Addition of berberine to formulated feed changes the glucose utilisation, intestinal microbiota and serum metabolites of largemouth bass (Micropterus salmoides). Aquaculture Reports, 23, 101018. https://doi.org/10.1016/j.aqrep.2022.101018"}, {"Citation": "Xiao, L., Xue, Y., Zhang, C., Wang, L., Lin, Y., & Pan, G. (2018). The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine. Xenobiotica, 48(3), 314-323. https://doi.org/10.1080/00498254.2017.1300707"}, {"Citation": "Xin, H.-W., Wu, X.-C., Li, Q., Yu, A.-R., Zhong, M.-Y., & Liu, Y.-Y. (2006). The effects of berberine on the pharmacokinetics of ciclosporin a in healthy volunteers. Methods and Findings in Experimental and Clinical Pharmacology, 28(1), 25-29. https://doi.org/10.1358/mf.2006.28.1.962774"}, {"Citation": "Xiong, W., Xiong, S. H., Chen, Q. L., Linghu, K. G., Zhao, G. D., Chu, J. M. T., \u2026 Yu, H. (2021). Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs. Carbohydrate Polymers, 266, 118112. https://doi.org/10.1016/j.carbpol.2021.118112"}, {"Citation": "Xu, B., Jiang, X., Xiong, J., Lan, J., Tian, Y., Zhong, L., \u2026 Hu, T. (2020). Structure-activity relationship study enables the discovery of a novel berberine analogue as the RXR\u03b1 activator to inhibit colon cancer. Journal of Medicinal Chemistry, 63(11), 5841-5855. https://doi.org/10.1021/acs.jmedchem.0c00088"}, {"Citation": "Xu, D., Qiu, C., Wang, Y., Qiao, T., & Cui, Y. L. (2021). Intranasal co-delivery of berberine and evodiamine by self-assembled thermosensitive in-situ hydrogels for improving depressive disorder. International Journal of Pharmaceutics, 603, 120667. https://doi.org/10.1016/j.ijpharm.2021.120667"}, {"Citation": "Yang, Q. C., Wu, W. H., Han, F. M., & Chen, Y. (2009). Identification of in-vivo and in-vitro metabolites of palmatine by liquid chromatography-tandem mass spectrometry. Journal of Pharmacy and Pharmacology, 61(5), 647-652. https://doi.org/10.1211/jpp/61.05.0014"}, {"Citation": "Yu, Q., Li, M., Chen, H., Xu, L., Cheng, J., Lin, G., \u2026 Xie, J. (2022). The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: A neglected carrier underlying its pharmacokinetics. Drug Delivery, 29(1), 856-870. https://doi.org/10.1080/10717544.2022.2036870"}, {"Citation": "Zhang, L., Han, L., Ma, J., Wu, T., Wei, Y., Zhao, L., & Tong, X. (2022). Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology. European Journal of Pharmacology, 919, 174769. https://doi.org/10.1016/j.ejphar.2022.174769"}, {"Citation": "Zhang, L., Wu, X., Yang, R., Chen, F., & Liao, Y. (2021). Effects of Berberine on the gastrointestinal microbiota. Frontiers in Cellular and Infection Microbiology, 10, 588517. https://doi.org/10.3389/fcimb.2020.588517"}, {"Citation": "Zhang, L., Li, M., Zhang, G., Gao, C., Wang, S., Zhang, T., \u2026 Zhu, Q. (2021). Micro- and nanoencapsulated hybrid delivery system (MNEHDS): A novel approach for colon-targeted oral delivery of berberine. Molecular Pharmaceutics, 18(4), 1573-1581. https://doi.org/10.1021/acs.molpharmaceut.0c00970"}, {"Citation": "Zhang, M., Zhang, Y., Xiao, D., Zhang, J., Wang, X., Guan, F., \u2026 Chen, L. (2020). Highly bioavailable berberine formulation ameliorates diabetic nephropathy through the inhibition of glomerular mesangial matrix expansion and the activation of autophagy. European Journal of Pharmacology, 873, 172955. https://doi.org/10.1016/j.ejphar.2020.172955"}, {"Citation": "Zhang, Y., Ting, Y., Qi, Y., Yan, X. X., Wang, W. J., Tian, X. T., \u2026 Pan, G. Y. (2019). Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity. Acta Pharmacologica Sinica, 40(1), 133-142. https://doi.org/10.1038/s41401-018-0183-7"}, {"Citation": "Zhao, Y., Roy, S., Wang, C., & Goel, A. (2022). A combined treatment with berberine and andrographis exhibits enhanced anti-cancer activity through suppression of DNA replication in colorectal cancer. Pharmaceuticals, 15(3), 262. https://doi.org/10.3390/ph15030262"}, {"Citation": "Zhao, Y., Yang, Y.-Y., Yang, B.-L., Du, Y.-W., Ren, D.-W., Zhou, H.-M., \u2026 Wu, S.-X. (2021). Efficacy and safety of berberine for dyslipidemia: Study protocol for a randomized double-blind placebo-controlled trial. Trials, 22(1), 85. https://doi.org/10.1186/s13063-021-05028-8"}, {"Citation": "Zhaojie, M., Ming, Z., Shengnan, W., Xiaojia, B., Hatch, G. M., Jingkai, G., & Li, C. (2014). Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability. International Journal of Pharmaceutics, 467(1-2), 50-59. https://doi.org/10.1016/j.ijpharm.2014.03.017"}, {"Citation": "Zhou, H., Shi, R., Ma, B., Ma, Y., Wang, C., Wu, D., \u2026 Cheng, N. (2013). CYP450 1A2 and multiple UGT1A isoforms are responsible for jatrorrhizine metabolism in human liver microsomes. Biopharmaceutics and Drug Disposition, 34(3), 176-185. https://doi.org/10.1002/bdd.1835"}, {"Citation": "Zhou, H., Li, W., Sun, L., Li, W., & Liu, Q. (2021). A rapid LC-MS/MS method for simultaneous determination of berberine and irbesartan in rat plasma: Application to the drug-drug pharmacokinetic interaction study after oral administration in rats. Biomedical Chromatography, 35(9), e5144. https://doi.org/10.1002/bmc.5144"}, {"Citation": "Zhou, Y., He, P., Liu, A., Zhang, L., Liu, Y., & Dai, R. (2012). Drug-drug interactions between ketoconazole and Berberine in rats: Pharmacokinetic effects benefit pharmacodynamic synergism. Phytotherapy Research, 26(5), 772-777. https://doi.org/10.1002/ptr.3621"}, {"Citation": "Zuo, F., Nakamura, N., Akao, T., & Hattori, M. (2006). Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metabolism and Disposition, 34(12), 2064-2072. https://doi.org/10.1124/dmd.106.011361"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2022", "Month": "7", "Day": "18"}, {"Year": "2022", "Month": "4", "Day": "23"}, {"Year": "2022", "Month": "8", "Day": "3"}, {"Year": "2022", "Month": "10", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "12", "Hour": "2", "Minute": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36221815", "10.1002/ptr.7589"]}}], "PubmedBookArticle": []}